KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Castle Biosciences (CSTL) Receivables - Net (2018 - 2026)

Castle Biosciences' Receivables - Net history spans 8 years, with the latest figure at $43.4 million for Q4 2025.

  • On a quarterly basis, Receivables - Net fell 15.3% to $43.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $43.4 million, a 15.3% decrease, with the full-year FY2025 number at $43.4 million, down 15.3% from a year prior.
  • Receivables - Net hit $43.4 million in Q4 2025 for Castle Biosciences, down from $49.5 million in the prior quarter.
  • Over the last five years, Receivables - Net for CSTL hit a ceiling of $56.4 million in Q1 2025 and a floor of $14.3 million in Q1 2021.
  • Historically, Receivables - Net has averaged $34.1 million across 5 years, with a median of $34.2 million in 2023.
  • Biggest five-year swings in Receivables - Net: soared 63.15% in 2023 and later fell 15.3% in 2025.
  • Tracing CSTL's Receivables - Net over 5 years: stood at $17.3 million in 2021, then soared by 35.84% to $23.5 million in 2022, then surged by 63.15% to $38.3 million in 2023, then surged by 33.72% to $51.2 million in 2024, then dropped by 15.3% to $43.4 million in 2025.
  • Business Quant data shows Receivables - Net for CSTL at $43.4 million in Q4 2025, $49.5 million in Q3 2025, and $52.3 million in Q2 2025.